Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-09-27

Clinical Trial Update: Double-Blind Lamictal (Lamotrigine) in Neurotic Excoriation [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating lamotrigine (Lamictal) for neurotic excoriation/pathologic skin picking has completed; results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LAMICTAL (LAMOTRIGINE)

Snippet

Sponsor: University of Chicago | Conditions: Neurotic Excoriation, Pathologic Skin Picking | Phase 2 | Status: COMPLETED | Results posted: 2013-09-27